ARTICLES ON VALVULOPATHIES
New tools for the surgical treatment of complex tricuspid regurgitation
Review emphasizing the experience of San Raffaele Hospital in the surgical management of tricuspid regurgitation when annuloplasty alone is insufficient, using clover and edge-to-edge repair techniques.
Treatment of transcatheter aortic valve (TAVI) thrombosis: a critical analysis
A review of the incidence, classification, and potential recommendations for clinical management of thrombosis associated with TAVI.
Percutaneous repair to treat functional mitral regurgitation: edge-to-edge therapies are here to stay
A meta-analysis summarizing current evidence from the three main studies on the use of edge-to-edge therapies to treat moderate-to-severe functional mitral regurgitation in patients with symptomatic heart failure.
What can structural interventions offer in heart failure? beyond valvular diseases
A bibliographic review of the current percutaneous devices available for the treatment of heart failure, including interventions on cardiac valves, left ventricular remodeling, or other approaches.
Aortic stenosis in asymptomatic patients: Early intervention doesn’t make the sun rise any sooner
Review of the current evidence on the invasive treatment of severe aortic stenosis in asymptomatic patients, with special emphasis on the results from the EVOLVED and EARLY-TAVR trials.
Percutaneous mitral repair vs. surgery in secondary mitral regurgitation
Analysis of the MATTERHORN trial on the efficacy and safety of two therapeutic approaches for treating secondary mitral regurgitation in patients with heart failure and optimal medical therapy: transcatheter edge-to-edge repair and mitral valve surgery (repair or replacement).
Aortic Stenosis and Stable Coronary Artery Disease: What Should We Address First? TAVI-PCI Study
Analysis of evidence on the optimal timing for performing percutaneous coronary intervention (PCI) in TAVI candidates, along with an outline of the TAVI-PCI study protocol.
Melody prosthesis: Is it an effective alternative as a bridge to mechanical valve replacement in young children?
Updated results on the Melody bovine jugular vein bioprosthesis as a strategy to gain time before definitive prosthetic valve replacement in pediatric patients with non-repairable mitral regurgitation.
The management of secondary mitral regurgitation. A paradigm shift
This commentary addresses a comprehensive review on the current management of secondary mitral regurgitation (sMR).
Mitral valve replacement in children: five-year outcomes from the HALO trial
This prospective, multicenter, single-arm clinical trial evaluates the efficacy and safety of the 15-mm St. Jude Medical Masters HP® mechanical mitral valve over five years in pediatric patients under five years of age.